2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Molecular Mechanisms of Delayed Kidney Graft Function

119.4 - Rho-Kinase inhibition mediated by hydroxyfasudil reduces alterations in gene expression profile associated with renal ischemia-reperfusion injury in a rat model of acute renal failure

Presenter: Dominik, Kentrup, Münster, Germany
Authors: Kentrup D., Reuter S., Edemir B., Grabner A., Pavenstädt H., Schlatter E., Büssemaker E.

RHO-KINASE INHIBITION MEDIATED BY HYDROXYFASUDIL REDUCES ALTERATIONS IN GENE EXPRESSION PROFILE ASSOCIATED WITH RENAL ISCHEMIA-REPERFUSION INJURY IN A RAT MODEL OF ACUTE RENAL FAILURE

MOLECULAR MECHANISMS OF DELAYED KIDNEY GRAFT FUNCTION

D. Kentrup, S. Reuter, B. Edemir, A. Grabner, H. Pavenstädt, E. Schlatter, E. Büssemaker
Experimentelle Nephrologie, Medizinische Klinik Und Poliklinik D, Universitätsklinikum Münster, Münster/GERMANY

Body: Introduction: One of the main causes of acute renal failure following (renal) surgery, transplantation or trauma is renal ischemia-reperfusion injury (IRI). Due to the important role of cytoskeletal reorganization in these processes, mainly regulated by Rho GTPases, we hypothesized that blockade of the Rho effector Rho-associated coiled-coil containing protein kinase (ROCK) may improve renal IRI outcome. Since IRI triggers a complex cascade of events in the affected organ systems, involving an intricate network of several different pathways, microarray analysis provided a suitable analytical approach. Methods: Male Sprague Dawley rats were unilaterally nephrectomized one week before inducing IRI by clamping the left renal artery for 45 min. Rats were divided into two groups: One h before the ischemia procedure rats received either 10 mg/kg hydroxyfasudil (HF, i.p.) or vehicle (CTR, isotonic NaCl). During the reperfusion phase following the operation rats were housed for 1-4 d in metabolic cages; blood and urine samples were taken daily for analysis. Microarray analysis was performed on kidneys of both groups, which were harvested on post operative day 4, as well as on kidneys from unilaterally nephrectomized rats. Data are given as mean values ± SEM. Results: Rats treated with HF showed a significantly improved creatinine-clearance (HF: 0.54 ± 0.03 ml/min/100 g vs. CTR: 0.14 ± 0.02 ml/min/100 g, n=6, p < 0.01) as well as fractional Na+-excretion (HF: 0.23 ± 0.04 % vs. CTR: 0.64 ± 0.22 %, n=6, p < 0.01) when compared to sham treated controls. Microarray analysis showed that 1115 genes were differentially expressed after IRI compared to unilaterally nephrectomized rats. Functional annotation showed that, among others, genes related to cell-cell signaling (151 genes), cellular movement (144 genes), cell death (200 genes), inflammatory responses (123 genes) and immune cell trafficking (84 genes) were overrepresented. The changes in gene expression were significantly reduced by HF-treatment. Conclusion: Attenuation of renal IRI via hydroxyfasudil mediated ROCK-inhibition was paralleled by a reduced alteration of the gene expression profile. Therefore, ROCK-inhibition is a potential therapeutic target in renal IRI.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada